about
Activities of fluconazole and voriconazole against 1,586 recent clinical isolates of Candida species determined by Broth microdilution, disk diffusion, and Etest methods: report from the ARTEMIS Global Antifungal Susceptibility Program, 2001In vitro activities of 5-fluorocytosine against 8,803 clinical isolates of Candida spp.: global assessment of primary resistance using National Committee for Clinical Laboratory Standards susceptibility testing methods.Comparative evaluation of a new fluorescent carboxyfluorescein diacetate-modified microdilution method for antifungal susceptibility testing of Candida albicans isolates.Human pharmacogenomic variations and their implications for antifungal efficacy.Invasive aspergillosis in patients with hematologic malignancies.Therapy of systemic fungal infections.Pharmacokinetics of antifungal agents in children.Triazole use in the nursery: fluconazole, voriconazole, posaconazole, and ravuconazoleAntifungal prophylaxis following reduced-intensity stem cell transplantation.Efficacy, safety, and plasma pharmacokinetics of escalating dosages of intravenously administered ravuconazole lysine phosphoester for treatment of experimental pulmonary aspergillosis in persistently neutropenic rabbits.Pediatric antifungal agents.In vitro activities of caspofungin compared with those of fluconazole and itraconazole against 3,959 clinical isolates of Candida spp., including 157 fluconazole-resistant isolates.Role of Candida albicans transcription factor Upc2p in drug resistance and sterol metabolismIn vitro activity and in vivo efficacy of icofungipen (PLD-118), a novel oral antifungal agent, against the pathogenic yeast Candida albicans.Medical management approach to infectious keratitis.Successful voriconazole therapy of disseminated Fusarium solani in the brain of a neutropenic cancer patient.Pseudoporphyria as a result of voriconazole use: a case report.
P2860
Q30452998-EEF61C2C-BF42-4890-823B-A90289E1EB40Q34142406-D605935C-03E9-4D45-B142-E1495891B64BQ34143149-258D46C5-B665-48D0-928B-F18FF9C81D48Q35070838-66BC9D0B-A38F-48B7-B646-B819258E9F33Q35616161-B4885800-77BB-4D35-97CA-2DDD2015231EQ35967453-1A890920-B2AA-4CAC-A019-502CEC3FACCFQ36163345-9631E5E8-D7F4-44E8-9EE3-28F53E44D7EAQ36521993-4B8A50FB-343D-40B5-B637-1954F11F1FF8Q36658236-79368D6B-F936-4C13-BA96-5AD4B0DC5D98Q37119029-BB330050-BFBE-424F-807B-25B98DD283B4Q37594515-9B26B9A9-96E2-4199-8214-438A3DF235C6Q39731811-84C8405F-53E6-4FCB-BE10-CE322118441FQ40737822-EF5040ED-B7FD-445B-B221-F361CDB570C4Q43152151-42298E20-78C5-477E-8AE8-8389DF0F6617Q43187227-DA5C06E4-5FD7-48A8-92EF-D860348E3C8BQ44634373-9F336366-26C1-4F70-B2B3-8401A88158ABQ45107364-36CDFAEC-0E18-46B9-A0B4-476C6A4BF087
P2860
description
2001 nî lūn-bûn
@nan
2001 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Investigational antifungal agents.
@ast
Investigational antifungal agents.
@en
Investigational antifungal agents.
@nl
type
label
Investigational antifungal agents.
@ast
Investigational antifungal agents.
@en
Investigational antifungal agents.
@nl
prefLabel
Investigational antifungal agents.
@ast
Investigational antifungal agents.
@en
Investigational antifungal agents.
@nl
P2860
P1433
P1476
Investigational antifungal agents
@en
P2093
P2860
P304
P356
10.1592/PHCO.21.12.165S.34509
P407
P433
P577
2001-08-01T00:00:00Z